These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15885354)

  • 1. Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.
    Chung Moh M; Hoon Lee L; Shen S
    J Hepatol; 2005 Jun; 42(6):833-41. PubMed ID: 15885354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma.
    Yamamoto Y; Sakamoto M; Fujii G; Kanetaka K; Asaka M; Hirohashi S
    Clin Cancer Res; 2001 Feb; 7(2):297-303. PubMed ID: 11234883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional significance of the hepaCAM gene in bladder cancer.
    He Y; Wu X; Luo C; Wang L; Lin J
    BMC Cancer; 2010 Mar; 10():83. PubMed ID: 20205955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells.
    Lee LH; Moh MC; Zhang T; Shen S
    J Cell Biochem; 2009 Aug; 107(6):1129-38. PubMed ID: 19507233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
    Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
    Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.
    Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX
    Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
    Zhang P; Chan DW; Zhu Y; Li JJ; Ng IO; Wan D; Gu J
    Clin Cancer Res; 2006 Nov; 12(22):6617-25. PubMed ID: 17121880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
    Xu KS; Wang HF; Qian W; Wang BH
    Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma.
    Nissom PM; Lo SL; Lo JC; Ong PF; Lim JW; Ou K; Liang RC; Seow TK; Chung MC
    FEBS Lett; 2006 Apr; 580(9):2216-26. PubMed ID: 16574106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.
    Zhao X; Li J; He Y; Lan F; Fu L; Guo J; Zhao R; Ye Y; He M; Chong W; Chen J; Zhang L; Yang N; Xu B; Wu M; Wan D; Gu J
    Cancer Res; 2001 Oct; 61(20):7383-7. PubMed ID: 11606366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma.
    Lin YW; Yan MD; Shih YL; Hsieh CB
    Eur J Cancer; 2009 Jul; 45(11):2041-9. PubMed ID: 19410446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cloning and characterization of syap1, a down regulated gene in human hepatocellular carcinoma].
    Chang YC; Yu YL; Wang N; Xu YH
    Shi Yan Sheng Wu Xue Bao; 2001 Dec; 34(4):319-22. PubMed ID: 12549212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.
    Miyasaka Y; Enomoto N; Nagayama K; Izumi N; Marumo F; Watanabe M; Sato C
    Br J Cancer; 2001 Jul; 85(2):228-34. PubMed ID: 11461082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.